Stefahn Herrmann

Stefahn Herrmann has a diverse work experience spanning several industries. Stefahn currently serves as the Commercial Director and Head of Site Development at Sanoptis, Augenklinik Dr. Hoffmann since July 2021. Prior to this, they worked as a Key Account Manager for Rare Diseases at Intercept Pharmaceuticals starting from March 2021.

Before joining Intercept Pharmaceuticals, Stefahn was the Head of Site Development at Augenpraxisklinik Stadthagen from June 2017 to March 2021. Stefahn also held various positions at Allergan, including Pharmareferent from October 2005 to May 2017 and Key Account Manager from October 2005 to December 2006.

Stefahn began their career as a Pharmareferent at Essex Pharma GmbH from January 2003 to September 2005. Prior to that, they worked as a Bezirksleiter Vertrieb at Abbott from January 1991 to January 2003. Stefahn also gained experience as a Pharmareferent at Astra Pharmaceuticals from January 1989 to January 1991.

Before entering the pharmaceutical industry, Stefahn worked at Reiner u. Stefahn Herrmann as a Versicherungsmaklerbüro from January 1987 to January 1989.

Overall, Stefahn Herrmann's work experience includes positions in pharmaceutical sales, key account management, site development, and commercial leadership.

Stefahn Herrmann received their Hochschulreife degree in Wirtschaftswissenschaften from Fachhochschule Wirtschaft Rheine in 1987, after completing their studies there from 1986 to 1987.